China Real Time Pcr, Digital Pcr, And End Point Pcr Market Size & Outlook
Related Markets
China real time pcr, digital pcr, and end point pcr market highlights
- The China real time pcr, digital pcr, and end point pcr market generated a revenue of USD 552.6 million in 2023 and is expected to reach USD 670.1 million by 2030.
- The China market is expected to grow at a CAGR of 2.8% from 2024 to 2030.
- In terms of segment, quantitative was the largest revenue generating technology in 2023.
- Digital is the most lucrative technology segment registering the fastest growth during the forecast period.
Real time pcr, digital pcr, and end point pcr market data book summary
| Market revenue in 2023 | USD 552.6 million |
| Market revenue in 2030 | USD 670.1 million |
| Growth rate | 2.8% (CAGR from 2023 to 2030) |
| Largest segment | Quantitative |
| Fastest growing segment | Digital |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Quantitative, Digital, End-point |
| Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
Other key industry trends
- In terms of revenue, China accounted for 7.2% of the global real time pcr, digital pcr, and end point pcr market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China real time pcr, digital pcr, and end point pcr market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 479.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real Time PCR, Digital PCR, And End Point PCR Market Scope
Real Time PCR, Digital PCR, And End Point PCR Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fluidigm Corporation | View profile | 501-1000 | South San Francisco, California, United States, North America | https://www.fluidigm.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE Aerospace | View profile | 125000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | https://www.geaerospace.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
China real time pcr, digital pcr, and end point pcr market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 85.23% in 2023. Horizon Databook has segmented the China real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
In 2023, China held a substantial share of the Asia Pacific market. Growth in the market can be attributed to the presence of local manufacturers and the increasing export of new PCR kits. For instance, in September 2022, QuantuMDx collaborated with Sansure Biotech to commercialize Q-POC and its assay in China.
China, one of the world’s largest chemical producers, expedited the development of testing kits. China plays a crucial role in sending supplies for testing to other countries. Over 100 companies in China are selling kits to European countries.
Companies in the country are constantly involved in product development. For instance, in December 2020, The company is also aiming to commercialize its NGS-based cancer diagnostic technologies. These innovations are expected to drive the market over the forecast period.
Reasons to subscribe to China real time pcr, digital pcr, and end point pcr market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China real time pcr, digital pcr, and end point pcr market databook
-
Our clientele includes a mix of real time pcr, digital pcr, and end point pcr market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into China real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China real time pcr, digital pcr, and end point pcr market size, by product, 2018-2030 (US$M)
China Real Time PCR, Digital PCR, And End Point PCR Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
